Streetbeat News

Earnings

SP

SP Plus (NASDAQ:SP) reported Q1 2024 earnings of $0.61 per share, missing the consensus estimate of $0.67. Sales were $222.1M, also below the $229M estimate, marking a 2.68% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:10 pm

CW

Curtiss-Wright reported Q1 2024 adjusted EPS of $1.99, surpassing the $1.74 estimate, with sales of $713.17M exceeding the $663.93M forecast, marking a 13.05% year-over-year increase.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:10 pm

MYRG

MYR Group reported Q1 2024 earnings of $1.12 per share, missing the $1.19 estimate, and sales of $815.562M, below the $854.134M estimate. This represents an 18.84% decrease in earnings and a 0.49% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:10 pm

GIL

Gildan Activewear has reaffirmed its adjusted earnings per share (EPS) forecast for fiscal year 2024 to be in the range of $2.92 to $3.07, aligning closely with the analyst estimate of $2.96.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:10 pm

RSI

Rush Street Interactive (NYSE:RSI) reported Q1 earnings of $0.03 per share, surpassing the $(0.02) estimate, marking a 250% beat and a 137.5% increase from last year's $(0.08) per share loss. Sales reached $217.43M, exceeding the $196.88M estimate by 10.44% and showing a 33.92% increase from last year's $162.36M.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:09 pm

CSV

Carriage Services has reaffirmed its financial outlook for fiscal year 2024, indicating confidence in its future performance.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:09 pm

ASPN

Aspen Aerogels (NYSE:ASPN) reported Q1 EPS of $(0.02), surpassing the $(0.11) estimate, and sales of $94.50M, exceeding the $75.00M estimate. This represents significant improvements over the previous year, with a 91.67% decrease in losses and a 107.30% increase in sales.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:08 pm

JAZZ

Jazz Pharmaceuticals reported Q1 2024 adjusted EPS of $2.68, missing the $4.18 estimate, and sales of $901.983M, missing the $953.896M estimate. This represents a 1.03% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:08 pm

BV

BrightView Holdings has revised its FY24 revenue forecast downwards from the previous range of $2.825B-$2.975B to a new range of $2.74B-$2.80B, which is below the estimated $2.844B.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:08 pm

AMWL

American Well (AMWL) reported Q1 2024 GAAP EPS of $(0.25), missing the $(0.19) estimate, with sales of $59.522M also missing the $60.524M estimate, marking a 7.00% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 9:07 pm